Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine prophylaxis for opioid-induced constipation in cancer patients
jRCTs031200397Completed
- Sponsor
- Japanese Society for Palliative Medicine
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer pain and opioid-induced constipation (OIC) comparing Naldemedine arm with Placebo arm (2 arms). Primary endpoint: Bowel Function Index responder rate at Day 14. Started Jul 2021; status: completed.
02
Drugs
naldemedine
03
Conditions
cancer painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on jRCTs031200397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200397.